Sale Reduces Cash Burn, Includes Seven-Year Earn-Out Provision;Third Quarter Revenue Expected to be Approximately $2.5 Million; Active Customer Sites Increase 18% YoY SOUTH ORANGE, NJ, Oct. 11, 2022 ...

BEVERLY, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen ...

When you think of electric fields, you likely think of electricity — the stuff that makes modern life possible by powering everything from household appliances to cellphones. Researchers have been ...

LexaGene Holdings, Inc., a molecular diagnostics company that develops fully automated, rapid pathogen detection systems, has successfully utilized the MiQLab™ System to detect the presence of a slow ...

Technologies needed for tracing engineered biothreats back to their sources are advancing rapidly. Here are some ...

FORT DETRICK, Md. – Researchers at the U.S. Army Medical Research Institute of Infectious Diseases are testing a promising new biological threat detection method in high-fidelity training scenarios, ...

The rapid spread of animal diseases and pathogen evolution have long posed significant threats to the healthy development of ...

DELRAY BEACH, Fla., Sept. 19, 2017 (GLOBE NEWSWIRE) -- One of the biggest barriers to delivering rapid diagnosis and care during a biological outbreak is about to be eliminated, said Lyle L. Probst, ...

The company has entered into an asset purchase agreement pursuant to which it will sell substantially all of its assets used in its PDS business to BWSI, a privately held firm that invests in ...